[go: up one dir, main page]

DK1307263T3 - Hidtil ukendt anvendelse af lipaseinhibitorer - Google Patents

Hidtil ukendt anvendelse af lipaseinhibitorer

Info

Publication number
DK1307263T3
DK1307263T3 DK01969436T DK01969436T DK1307263T3 DK 1307263 T3 DK1307263 T3 DK 1307263T3 DK 01969436 T DK01969436 T DK 01969436T DK 01969436 T DK01969436 T DK 01969436T DK 1307263 T3 DK1307263 T3 DK 1307263T3
Authority
DK
Denmark
Prior art keywords
lipase inhibitors
hitherto unknown
unknown use
hitherto
lipase
Prior art date
Application number
DK01969436T
Other languages
English (en)
Inventor
Paul Hadvary
Hans Lengsfeld
Hans Steffen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1307263T3 publication Critical patent/DK1307263T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK01969436T 2000-07-28 2001-07-19 Hidtil ukendt anvendelse af lipaseinhibitorer DK1307263T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00116392 2000-07-28
PCT/EP2001/008353 WO2002009814A2 (en) 2000-07-28 2001-07-19 New use of lipase inhibitors
EP01969436A EP1307263B1 (en) 2000-07-28 2001-07-19 New use of lipase inhibitors

Publications (1)

Publication Number Publication Date
DK1307263T3 true DK1307263T3 (da) 2005-08-22

Family

ID=8169383

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969436T DK1307263T3 (da) 2000-07-28 2001-07-19 Hidtil ukendt anvendelse af lipaseinhibitorer

Country Status (17)

Country Link
US (3) US6562329B2 (da)
EP (1) EP1307263B1 (da)
JP (2) JP4772264B2 (da)
KR (1) KR100556324B1 (da)
CN (1) CN1261094C (da)
AR (1) AR031117A1 (da)
AT (1) ATE293477T1 (da)
AU (2) AU2001289696B2 (da)
BR (1) BR0112800A (da)
CA (1) CA2416900C (da)
DE (1) DE60110232T2 (da)
DK (1) DK1307263T3 (da)
ES (1) ES2240516T3 (da)
MX (1) MXPA03000694A (da)
PT (1) PT1307263E (da)
WO (1) WO2002009814A2 (da)
ZA (1) ZA200300454B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001289696B2 (en) * 2000-07-28 2006-07-06 Cheplapharm Arzneimittel Gmbh New use of lipase inhibitors
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
ES2295369T3 (es) * 2001-07-30 2008-04-16 Mitsubishi Pharma Corporation Farmacos para mejorar la hiperglucemia postcibal.
US20050276781A1 (en) * 2004-06-09 2005-12-15 Ross Edward A Molecularly imprinted phosphate binders for therapeutic use
HUE026628T2 (en) * 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
CA2647325C (en) * 2005-12-12 2015-03-24 Allaccem, Inc. Methods and systems for preparing antimicrobial bridged polycyclic compounds
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
ITRM20060204A1 (it) 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
CA2673665C (en) 2006-12-22 2017-03-21 Ironwood Pharmaceuticals, Inc. Method and compositions for treating esophageal disorders
DK2125026T3 (da) 2007-02-21 2014-12-08 Allaccem Inc Sammensætninger baseret på broforbundne polycykliske forbindelser til hæmning og lindring af sygdomme
US20090023682A1 (en) * 2007-07-19 2009-01-22 Joseph Artiss Composition Comprising Dietary Fat Complexer and Methods of Using Same
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US8524212B2 (en) * 2007-10-24 2013-09-03 Mitsubishi Tanabe Pharma Corporation Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20110129433A1 (en) * 2008-06-26 2011-06-02 Ironwood Pharmaceuticals, Inc. Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders
US20100008988A1 (en) * 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
CN101791296B (zh) * 2010-01-17 2012-08-29 山东新时代药业有限公司 一种奥利司他片剂及其制备方法
PL2568827T3 (pl) * 2010-05-14 2018-10-31 Omega Pharma Innovation & Development Nv Kompozycja do redukowania wchłaniania tłuszczu przyjmowanego z pokarmem
WO2020213010A1 (en) * 2019-04-16 2020-10-22 Celagenex Research (India) Pvt. Ltd. Synergistic lipid controlling compositions
KR102271821B1 (ko) * 2020-12-18 2021-07-01 주식회사 엔테로바이옴 오를리스타트 및 아커만시아 뮤시니필라 eb-amdk19 균주를 포함하는 조성물
WO2022140261A1 (en) * 2020-12-22 2022-06-30 Ambys Medicines, Inc. Biliary delivery methods, compositions and kits for use therein
CN113057340B (zh) * 2021-04-29 2024-01-19 南京邮电大学 一种菌菇膳食纤维改性方法
WO2023023939A1 (en) * 2021-08-24 2023-03-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymers, compositions and methods for treating hyperuricemia
ES2995007T3 (en) * 2021-08-24 2025-02-05 Waterstone Pharmaceuticals Wuhan Co Ltd Polymers, compositions and methods for treating hyperuricemia

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
CA2035972C (en) 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5274143A (en) 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
US5616570A (en) * 1991-10-18 1997-04-01 Lange, Iii; Louis G. Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
DE69633502T2 (de) * 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
CA2340052C (en) 1998-08-14 2007-05-29 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors and chitosan
TR200100471T2 (tr) * 1998-08-14 2001-07-23 F.Hoffmann-La Roche Ag Lipaz inhibitörleri içeren farmasötik bileşimler
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
AU2001289696B2 (en) * 2000-07-28 2006-07-06 Cheplapharm Arzneimittel Gmbh New use of lipase inhibitors
ATE279961T1 (de) * 2000-07-28 2004-11-15 Hoffmann La Roche Neue pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
WO2002009814A2 (en) 2002-02-07
US20060189574A1 (en) 2006-08-24
ZA200300454B (en) 2004-04-16
ATE293477T1 (de) 2005-05-15
CA2416900C (en) 2007-07-03
AU8969601A (en) 2002-02-13
WO2002009814A3 (en) 2002-04-18
KR100556324B1 (ko) 2006-03-03
JP2004505066A (ja) 2004-02-19
CN1444496A (zh) 2003-09-24
US6562329B2 (en) 2003-05-13
AR031117A1 (es) 2003-09-10
JP2009108062A (ja) 2009-05-21
MXPA03000694A (es) 2003-06-04
DE60110232T2 (de) 2006-01-19
CN1261094C (zh) 2006-06-28
EP1307263A2 (en) 2003-05-07
KR20030069978A (ko) 2003-08-27
CA2416900A1 (en) 2002-02-07
AU2001289696B2 (en) 2006-07-06
US20020042395A1 (en) 2002-04-11
JP4772264B2 (ja) 2011-09-14
PT1307263E (pt) 2005-08-31
DE60110232D1 (de) 2005-05-25
EP1307263B1 (en) 2005-04-20
BR0112800A (pt) 2003-07-01
US20030138396A1 (en) 2003-07-24
ES2240516T3 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
DK1307263T3 (da) Hidtil ukendt anvendelse af lipaseinhibitorer
DK1315694T3 (da) Inhibitorer af alpha-4-medieret celleadhæsion
DK1183033T3 (da) Pyrrolotriazininhibitorer af kinaser
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
ATE370938T1 (de) Pro-pharmakon von cox-2-inhibitoren
DK1532138T3 (da) Inhibitorer af tyrosinkinaser
IS6289A (is) thríhringja hindrar af poly (ADP-ribosa) polymerösum
DK0984957T3 (da) Hidtil ukendt form af S-omeprazol
ID30590A (id) Celana sekali pakai jenis-celana pendek
DK1341779T3 (da) Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion
DK1064298T3 (da) Inhibitorer af caspaser
DK1042307T3 (da) Aminothiazolinhibitorer af cyclinafhængige kinaser
DK1077943T3 (da) Heterocykliske inhibitorer af p38
ATE433451T1 (de) Xanthin-phosphodiesteras-v-inhibitoren
DK1438306T3 (da) Derivater af UK-2A
DK1686113T3 (da) Inhibitorer af aspartylprotease
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
ID30187A (id) Dongkrak jenis pantagraf
ATE281181T1 (de) Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
AR028261A1 (es) Inhibidores triciclicos de la proteina quinasa
AR028281A1 (es) Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
DK1892239T3 (da) Inhibitorer af cytosol-phospholipase A2
IS6620A (is) Nýr fjölgervingur V af tórasemíði
DE60007360D1 (de) Amorphe modifikation von torasemid
IS6701A (is) Cdc25 fosfatasahemlar